Aims Diagnosis of inflammatory bowel disease (IBD) is often associated with a diagnostic delay. Although faecal calprotectin is a helpful screening tool, the widespread use in primary care (PC) may not be appropriate due to the low prevalence of IBD in this setting. To increase pretest probability for a positive calprotectin test, an 8‐item questionnaire (CalproQuest) was tested for its feasibility and acceptability in PC. Methods Population: PC patients with unspecific gastrointestinal complaints for at least 2 weeks. The CalproQuest consists of four major and four minor questions specific for IBD. It is considered positive if greater than or equal to two major or one major and two minor criteria are positive. Primary outcome: feasibility ...
Background/Aims Fecal calprotectin (fC) level is a predictive marker of mucosal healing for patients...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
Aim: The clinical presentation of inflammatory bowel disease in primary care represents a diagnostic...
Aims Diagnosis of inflammatory bowel disease (IBD) is often associated with a diagnostic delay. Alth...
INTRODUCTION: Diagnosis of inflammatory bowel disease (IBD) in primary healthcare is challenging and...
BACKGROUND: Diagnosis of inflammatory bowel disease (IBD) in primary care (PC) is challenging and a...
BackgroundDiagnosis of inflammatory bowel disease (IBD) in primary care (PC) is challenging and asso...
BACKGROUND: Faecal calprotectin (FC) measurement distinguishes patients with inflammatory bowel dise...
Objective: To determine the diagnostic accuracy of calprotectin to diagnose inflammatory bowel disea...
Background: Irritable bowel syndrome (IBS) is common, and causes pain, bloating and diarrhoea and/or...
Introduction: Despite its success, there appears to be practical issues with Faecal Calprotectin (FC...
Objective To evaluate whether including a test for faecal calprotectin, a sensitive marker of intest...
Objective To evaluate whether including a test for faecal calprotectin, a sensitive marker of intest...
Objective: Calgranulin-C (S100A12) is a new faecal marker of inflammation that is potentially more s...
Chronic or recurrent gastrointestinal symptoms are common presentations among children in primary ca...
Background/Aims Fecal calprotectin (fC) level is a predictive marker of mucosal healing for patients...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
Aim: The clinical presentation of inflammatory bowel disease in primary care represents a diagnostic...
Aims Diagnosis of inflammatory bowel disease (IBD) is often associated with a diagnostic delay. Alth...
INTRODUCTION: Diagnosis of inflammatory bowel disease (IBD) in primary healthcare is challenging and...
BACKGROUND: Diagnosis of inflammatory bowel disease (IBD) in primary care (PC) is challenging and a...
BackgroundDiagnosis of inflammatory bowel disease (IBD) in primary care (PC) is challenging and asso...
BACKGROUND: Faecal calprotectin (FC) measurement distinguishes patients with inflammatory bowel dise...
Objective: To determine the diagnostic accuracy of calprotectin to diagnose inflammatory bowel disea...
Background: Irritable bowel syndrome (IBS) is common, and causes pain, bloating and diarrhoea and/or...
Introduction: Despite its success, there appears to be practical issues with Faecal Calprotectin (FC...
Objective To evaluate whether including a test for faecal calprotectin, a sensitive marker of intest...
Objective To evaluate whether including a test for faecal calprotectin, a sensitive marker of intest...
Objective: Calgranulin-C (S100A12) is a new faecal marker of inflammation that is potentially more s...
Chronic or recurrent gastrointestinal symptoms are common presentations among children in primary ca...
Background/Aims Fecal calprotectin (fC) level is a predictive marker of mucosal healing for patients...
PURPOSE In specialist care, fecal calprotectin (FCal) is a commonly used noninvasive diagnostic test...
Aim: The clinical presentation of inflammatory bowel disease in primary care represents a diagnostic...